These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 22177841

  • 1. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.
    Chen Y, Chen H, Zhang S, Chen F, Sun S, He Q, Ma M, Wang X, Wu H, Zhang L, Zhang L, Shi J.
    Biomaterials; 2012 Mar; 33(7):2388-98. PubMed ID: 22177841
    [Abstract] [Full Text] [Related]

  • 2. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.
    Chen Y, Yin Q, Ji X, Zhang S, Chen H, Zheng Y, Sun Y, Qu H, Wang Z, Li Y, Wang X, Zhang K, Zhang L, Shi J.
    Biomaterials; 2012 Oct; 33(29):7126-37. PubMed ID: 22789722
    [Abstract] [Full Text] [Related]

  • 3. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.
    Li X, Zhao W, Liu X, Chen K, Zhu S, Shi P, Chen Y, Shi J.
    Acta Biomater; 2016 Jan; 30():378-387. PubMed ID: 26602820
    [Abstract] [Full Text] [Related]

  • 4. Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release.
    Zhang S, Qian X, Zhang L, Peng W, Chen Y.
    Nanoscale; 2015 May 07; 7(17):7632-43. PubMed ID: 25785502
    [Abstract] [Full Text] [Related]

  • 5. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
    Huang H, Yue T, Xu K, Golzarian J, Yu J, Huang J.
    Colloids Surf B Biointerfaces; 2015 Jul 01; 131():148-54. PubMed ID: 25982318
    [Abstract] [Full Text] [Related]

  • 6. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
    Guillet-Nicolas R, Laprise-Pelletier M, Nair MM, Chevallier P, Lagueux J, Gossuin Y, Laurent S, Kleitz F, Fortin MA.
    Nanoscale; 2013 Dec 07; 5(23):11499-511. PubMed ID: 24178890
    [Abstract] [Full Text] [Related]

  • 7. Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast-Enhanced in Vivo Imaging.
    Ren S, Yang J, Ma L, Li X, Wu W, Liu C, He J, Miao L.
    ACS Appl Mater Interfaces; 2018 Sep 26; 10(38):31947-31958. PubMed ID: 30179443
    [Abstract] [Full Text] [Related]

  • 8. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
    McDonagh BH, Singh G, Hak S, Bandyopadhyay S, Augestad IL, Peddis D, Sandvig I, Sandvig A, Glomm WR.
    Small; 2016 Jan 20; 12(3):301-6. PubMed ID: 26619158
    [Abstract] [Full Text] [Related]

  • 9. One-pot preparation of hydrophilic manganese oxide nanoparticles as T1 nano-contrast agent for molecular magnetic resonance imaging of renal carcinoma in vitro and in vivo.
    Li J, Wu C, Hou P, Zhang M, Xu K.
    Biosens Bioelectron; 2018 Apr 15; 102():1-8. PubMed ID: 29101783
    [Abstract] [Full Text] [Related]

  • 10. Luminescent GdVO4:Eu3+ functionalized mesoporous silica nanoparticles for magnetic resonance imaging and drug delivery.
    Huang S, Cheng Z, Ma P, Kang X, Dai Y, Lin J.
    Dalton Trans; 2013 May 14; 42(18):6523-30. PubMed ID: 23474744
    [Abstract] [Full Text] [Related]

  • 11. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles.
    Yu L, Chen Y, Wu M, Cai X, Yao H, Zhang L, Chen H, Shi J.
    J Am Chem Soc; 2016 Aug 10; 138(31):9881-94. PubMed ID: 27441571
    [Abstract] [Full Text] [Related]

  • 12. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
    Sahoo B, Devi KS, Dutta S, Maiti TK, Pramanik P, Dhara D.
    J Colloid Interface Sci; 2014 Oct 01; 431():31-41. PubMed ID: 24980623
    [Abstract] [Full Text] [Related]

  • 13. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W, Liu M, Liu A, Zhai G.
    Curr Pharm Des; 2017 Oct 01; 23(23):3367-3382. PubMed ID: 27784244
    [Abstract] [Full Text] [Related]

  • 14. Silica-F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T1 magnetic resonance relaxivity.
    Wei Hsu BY, Wang M, Zhang Y, Vijayaragavan V, Wong SY, Yuang-Chi Chang A, Bhakoo KK, Li X, Wang J.
    Nanoscale; 2014 Jan 07; 6(1):293-9. PubMed ID: 24193096
    [Abstract] [Full Text] [Related]

  • 15. PSA targeted dual-modality manganese oxide-mesoporous silica nanoparticles for prostate cancer imaging.
    Du D, Fu HJ, Ren WW, Li XL, Guo LH.
    Biomed Pharmacother; 2020 Jan 07; 121():109614. PubMed ID: 31731188
    [Abstract] [Full Text] [Related]

  • 16. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo.
    Liu Y, Ding X, Li J, Luo Z, Hu Y, Liu J, Dai L, Zhou J, Hou C, Cai K.
    Nanotechnology; 2015 Apr 10; 26(14):145102. PubMed ID: 25789511
    [Abstract] [Full Text] [Related]

  • 17. Real-time monitoring of arsenic trioxide release and delivery by activatable T(1) imaging.
    Zhao Z, Wang X, Zhang Z, Zhang H, Liu H, Zhu X, Li H, Chi X, Yin Z, Gao J.
    ACS Nano; 2015 Mar 24; 9(3):2749-59. PubMed ID: 25688714
    [Abstract] [Full Text] [Related]

  • 18. A Prussian Blue-Based Core-Shell Hollow-Structured Mesoporous Nanoparticle as a Smart Theranostic Agent with Ultrahigh pH-Responsive Longitudinal Relaxivity.
    Cai X, Gao W, Ma M, Wu M, Zhang L, Zheng Y, Chen H, Shi J.
    Adv Mater; 2015 Nov 04; 27(41):6382-9. PubMed ID: 26393889
    [Abstract] [Full Text] [Related]

  • 19. Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.
    Abbasi AZ, Prasad P, Cai P, He C, Foltz WD, Amini MA, Gordijo CR, Rauth AM, Wu XY.
    J Control Release; 2015 Jul 10; 209():186-96. PubMed ID: 25908171
    [Abstract] [Full Text] [Related]

  • 20. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X, Chen L, Yi Z, Li C, He C, Feng C, Wang T, Shigdar S, Duan W, Kong L.
    Mini Rev Med Chem; 2018 Jul 10; 18(11):976-989. PubMed ID: 27145854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.